These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16809153)

  • 1. Effect of leuprolide and cetrorelix on cell growth, apoptosis, and GnRH receptor expression in primary cell cultures from human prostate carcinoma.
    Castellón E; Clementi M; Hitschfeld C; Sánchez C; Benítez D; Sáenz L; Contreras H; Huidobro C
    Cancer Invest; 2006; 24(3):261-8. PubMed ID: 16809153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of GnRH analogs on the expression of TrkA and p75 neurotrophin receptors in primary cell cultures from human prostate adenocarcinoma.
    Sánchez C; Clementi M; Benitez D; Contreras H; Huidobro C; Castellón E
    Prostate; 2005 Nov; 65(3):195-202. PubMed ID: 15948150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotropin releasing hormone analogs induce apoptosis by extrinsic pathway involving p53 phosphorylation in primary cell cultures of human prostatic adenocarcinomas.
    Clementi M; Sánchez C; Benitez DA; Contreras HR; Huidobro C; Cabezas J; Acevedo C; Castellón EA
    Prostate; 2009 Jul; 69(10):1025-33. PubMed ID: 19301301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
    Schubert A; Schulz H; Emons G; Gründker C
    Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production.
    Britten JL; Malik M; Levy G; Mendoza M; Catherino WH
    Fertil Steril; 2012 Nov; 98(5):1299-307. PubMed ID: 22901846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin-releasing hormone agonists reduce the migratory and the invasive behavior of androgen-independent prostate cancer cells by interfering with the activity of IGF-I.
    Montagnani Marelli M; Moretti RM; Mai S; Procacci P; Limonta P
    Int J Oncol; 2007 Jan; 30(1):261-71. PubMed ID: 17143537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of gonadotropin-releasing hormone analogs and their conjugates on gonadotropin-releasing hormone receptor--positive human cancer cell lines.
    Pályi I; Vincze B; Kálnay A; Turi G; Mezõ I; Teplán I; Seprõdi J; Pató J; Móra M
    Cancer Detect Prev; 1996; 20(2):146-52. PubMed ID: 8706040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential inhibitory effects on human endometrial carcinoma cell growth of luteinizing hormone-releasing hormone analogues.
    Borri P; Coronnello M; Noci I; Pesciullesi A; Peri A; Caligiani R; Maggi M; Torricelli F; Scarselli G; Chieffi O; Mazzei T; Mini E
    Gynecol Oncol; 1998 Dec; 71(3):396-403. PubMed ID: 9887238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis-related gene expression affected by a GnRH analogue without induction of programmed cell death in LNCaP cells.
    Angelucci C; Iacopino F; Lama G; Capucci S; Zelano G; Boca M; Pistilli A; Sica G
    Anticancer Res; 2004; 24(5A):2729-38. PubMed ID: 15517879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin-releasing hormone receptor expression in the human prostate.
    Tieva A ; Stattin P; Wikström P; Bergh A; Damber JE
    Prostate; 2001 Jun; 47(4):276-84. PubMed ID: 11398175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GnRH-II antagonists induce apoptosis in human endometrial, ovarian, and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein Bax.
    Fister S; Günthert AR; Aicher B; Paulini KW; Emons G; Gründker C
    Cancer Res; 2009 Aug; 69(16):6473-81. PubMed ID: 19638591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of GnRH analogs on six ovarian cancer cell lines in culture.
    Connor JP; Buller RE; Conn PM
    Gynecol Oncol; 1994 Jul; 54(1):80-6. PubMed ID: 8020844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell growth effects of leuprolide on cultured endometrioma cells.
    Levine D; Kaufman L; Cuenca VG; Badawy SZ
    J Reprod Med; 2007 Jul; 52(7):581-4. PubMed ID: 17847754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GnRH agonist inhibits human telomerase reverse transcriptase mRNA expression in endometrial cancer cells.
    Nagai N; Oshita T; Mukai K; Shiroyama Y; Shigemasa K; Ohama K
    Int J Mol Med; 2002 Nov; 10(5):593-7. PubMed ID: 12373298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of gonadotropin-releasing hormone and its receptor in endometrial cancer, and its relevance as an autocrine growth factor.
    Chatzaki E; Bax CM; Eidne KA; Anderson L; Grudzinskas JG; Gallagher CJ
    Cancer Res; 1996 May; 56(9):2059-65. PubMed ID: 8616851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of serotonin (5-hydroxytryptamine1A and 1B) receptors in prostate cancer cell proliferation.
    Siddiqui EJ; Shabbir M; Mikhailidis DP; Thompson CS; Mumtaz FH
    J Urol; 2006 Oct; 176(4 Pt 1):1648-53. PubMed ID: 16952708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenomedullin (AM) and AM receptor type 2 expression is up-regulated in prostate carcinomas (PC), and AM stimulates in vitro growth of a PC-derived cell line by enhancing proliferation and decreasing apoptosis rates.
    Mazzocchi G; Malendowicz LK; Ziolkowska A; Spinazzi R; Rebuffat P; Aragona F; Ferrazzi E; Parnigotto PP; Nussdorfer GG
    Int J Oncol; 2004 Dec; 25(6):1781-7. PubMed ID: 15547717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of leuprorelin acetate on cell growth and prostate-specific antigen gene expression in human prostatic cancer cells.
    Sica G; Iacopino F; Settesoldi D; Zelano G
    Eur Urol; 1999; 35 Suppl 1():2-8. PubMed ID: 10081696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High incidence of receptors for luteinizing hormone-releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers.
    Halmos G; Arencibia JM; Schally AV; Davis R; Bostwick DG
    J Urol; 2000 Feb; 163(2):623-9. PubMed ID: 10647698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferation of TSU-Pr1, a human prostatic carcinoma cell line is stimulated by gonadotropin-releasing hormone.
    Enomoto M; Seong JY; Kawashima S; Park MK
    Life Sci; 2004 May; 74(25):3141-52. PubMed ID: 15081579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.